CtDNA Based MRD Testing for NAC Monitoring in TNBC

RecruitingOBSERVATIONAL
Enrollment

422

Participants

Timeline

Start Date

November 9, 2023

Primary Completion Date

August 30, 2025

Study Completion Date

December 31, 2025

Conditions
TNBC - Triple-Negative Breast CancerMinimal Residual Disease
Trial Locations (14)

11794

RECRUITING

Stony Brook University Cancer Center, Stony Brook

17403

RECRUITING

Cancer Care Associates of York, York

20037

RECRUITING

George Washington University, Washington D.C.

33140

RECRUITING

Mount Sinai Medical Center of Florida, Miami Beach

33709

RECRUITING

Comprehensive Hematology Oncology (ONare Alliance, LLC / Exigent Research, LLC, St. Petersburg

48197

RECRUITING

Trinity Health-Michigan, Ypsilanti

61615

RECRUITING

Illinois Cancer Care, Peoria

68114

RECRUITING

Nebraska Methodist, Omaha

70112

RECRUITING

Louisiana State University, New Orleans

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

80045

RECRUITING

University of Colorado Cancer Center, Aurora

85704

RECRUITING

Arizona Oncology, Tucson

97301

RECRUITING

Oregon Oncology Specialists, Salem

99202

RECRUITING

Cancer Care Northwest, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Personalis Inc.

INDUSTRY

NCT06230185 - CtDNA Based MRD Testing for NAC Monitoring in TNBC | Biotech Hunter | Biotech Hunter